Dikgram Aves Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 5.00 K
- Company Age 35 Year, 2 Months
- Open Charges ₹ 0.38 M
About Dikgram Aves Pharma
Dikgram Aves Pharma Pvt Ltd (DAPPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 December 1989 and has a history of 35 years and two months. Its registered office is in Hyderabad, Andhra Pradesh.
The Company is engaged in the Chemicals Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 5.00 K .
The company currently has active open charges totaling ₹0.38 M.
Company Details
-
LocationHyderabad, Andhra Pradesh
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230AP1989PTC010759
-
Company No.
010759
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 Dec 1989
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Dikgram Aves Pharma?
Board Members
![People](/Images/tcc-no-data-images/people-and-contacts.webp)
No Directors or KMP associated with company. Upon reviewing the records, we can confirm that there are no Directors or Key Management Personnel (KMP) associated with this company at present.
Financial Performance of Dikgram Aves Pharma.
Enhance accessibility to Dikgram Aves Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
![Graph illustrating revenue growth over time](/Images/financial/revenue-growth.webp)
![Graph showing profit and loss trends over time](/Images/financial/profit-loss.webp)
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Dikgram Aves Pharma?
Unlock access to Dikgram Aves Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
![Shareholding Indicator graph](/Images/tcc-login/Shareholding-Indiacator-1200.webp)
Charges (Loans)
₹0.38 M
₹0
Charges Breakdown by Lending Institutions
- Indian Bank : 0.04 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
13 Jan 1992 | Indian Bank | ₹0.38 M | Open |
How Many Employees Work at Dikgram Aves Pharma?
Unlock and access historical data on people associated with Dikgram Aves Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
![Graph showing employee growth trends](/Images/tcc-login/Employee-Graph.webp)
Deals i
![Graph showing company valuation over time](/Images/tcc-login/Valuation-Graph-small.webp)
Gain comprehensive insights into the Deals and Valuation data of Dikgram Aves Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dikgram Aves Pharma's trajectory.
Rating
![Graph displaying rating trends over time](/Images/tcc-login/Rating-Graph-small.webp)
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
![Alert Indicator](/Images/tcc-login/Alert-Indicator-small.webp)
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.